Form 4 for RMD ResMed|
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-20 · accession 0001127602-24-027902 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-20 | RMD | De Witte Jan | Dir | A - Grant | $0.00 | +1,083 | 7,806 | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2024-11-20 | A | A | 1,083 | $0.00 | 7,806 | D | — | — |